Edesa Biotech Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +103.9% | +67.6% | -82.0% | -7.2% | +93.9% | -20.0% | -99.8% | -100.0% | – | – | – | |
| – | +10.5% | +34.2% | -52.6% | -16.7% | -77.3% | -82.6% | +574.9% | -0.5% | +55.2% | +1.4% | -35.9% | |
| – | – | – | -312.8% | – | – | +0.5% | -138.2% | – | – | – | – | |
| – | -58.1% | +68.0% | +14.1% | +5.8% | -47.5% | +203.7% | +439.0% | -25.7% | -64.0% | -39.9% | +27.3% | |
| – | +12.4% | +3.0% | -11.4% | -6.4% | -25.8% | +65.4% | +69.5% | -12.2% | -12.1% | -6.7% | +2.7% | |
| – | -20.1% | +18.7% | -2.6% | -1.5% | -35.2% | +113.6% | +252.8% | -22.4% | -49.8% | -23.9% | +11.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +67.1% | +23.1% | +603.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +35.3% | -80.4% | -88.9% | +0.0% | -7,025.5% | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.